The only FDA-approved CGM System that lets you make treatment decisions without pricking your finger.**
See your number every five minutes – and where it’s heading – with just a glance at your compatible smart device1 or Dexcom Receiver, whether you’re in a meeting, on an airplane or on a first date.
** Fingersticks required for calibration, or if symptoms or expectations do not match readings, or when taking medications containing acetaminophen.
Unlike a blood glucose meter (BGM), which provides just a single glucose reading, CGM systems provide real-time, dynamic glucose information every five minutes — up to 288 readings in a 24-hour period. You can gain valuable insight about your glucose levels, speed, and direction giving you additional insight to proactively manage your diabetes.
CGM has proven to be the best outpatient glycemic management system for reducing A1C. Type 1 diabetics experience an average A1C reduction of 1.3%.**1
Not only can CGM use reduce A1C, numerous studies have shown it can also decrease time spent in hypoglycemia.1-3
CGM systems are equipped with alerts that warn you of approaching lows and highs.
Take the next step with Dexcom
** Fingersticks required for calibration, or if symptoms or expectations do not match readings, or when taking medications containing acetaminophen.
1 Click here for a list of compatible devices.
2 dQ&A market research study, 2016
3 Dexcom G5 Mobile user guide, 2017
BRIEF SAFETY STATEMENT The Dexcom G5 Mobile Continuous Glucose Monitoring (CGM) System ("G5") is a glucose monitoring system indicated for the management of diabetes in persons age 2 years and older. The G5 is designed to replace fingerstick blood glucose testing for diabetes treatment decisions. The G5 also aids in the detection of episodes of hyperglycemia and hypoglycemia. The G5 is intended for single patient use and requires a prescription. CONTRAINDICATIONS Do not rely on the G5 CGM data if you have recently taken acetaminophen. Remove the G5 (sensor, transmitter, and receiver) before Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scan, or high-frequency electrical heat (diathermy) treatment. The G5 is MR Unsafe. Do not bring any portion of the G5 into the MRI environment. WARNING CGM-based diabetes treatment decisions are only approved with the G5, not previous generations of Dexcom CGM systems. Calibrate at least once every 12 hours using a fingerstick. If your G5 does not display a sensor glucose reading and an arrow, or if you are getting inaccurate or inconsistent readings, take a fingerstick. If your glucose readings and alerts do not match your symptoms or expectations, take a fingerstick to confirm. Failure to do so may lead to hyperglycemia or hypoglycemia. The G5 is not approved for use in pregnant women, persons on dialysis or critically ill persons. If a sensor breaks and no portion of it is visible above the skin, do not attempt to remove it. Seek professional medical help if you have infection or inflammation on or near the sensor insertion point. Report broken sensors to Dexcom Technical Support. Sensor placement is not approved for sites other than under the skin of the belly (ages 2 years and older) or upper buttocks (ages 2-17 years). To “share” data, you need an internet connection and a separate compatible smart device running the Dexcom Follow App. Contact Dexcom Toll Free at 877-339-2664 or www.dexcom.com for detailed indications for use and safety information.
© 2017 Dexcom Inc. All rights reserved. This product is covered by U.S. patent.